Intellectual Property
Every innovation that improves lives, advances society, and drives our economy starts with an idea. Strong intellectual property rights—including patents, trademarks, and copyrights—protect and incentivize those ideas. When inventors, researchers, engineers, artists, and entrepreneurs have legal certainty that their work will be protected and rewarded, they can keep the transformative ideas coming. Intellectual property protections also shield consumers from dangerous fake and counterfeit goods, giving people assurances that products—from life-saving medicines to toys—are safe and authentic.
2023 International IP Index
Now in the eleventh edition, the International IP Index benchmarks the IP framework in 55 global economies across 50 unique indicators.
Learn More
Feature story
When we recognize and address challenges that women innovators, creators, and entrepreneurs face and when we foster more inclusion and creativity, all of society benefits.
Feature video
Government leaders and industry experts discussed how public-private partnerships can help stop counterfeiting.
Further reading
- New Amazon Report Shows Dedication to Protecting Brands and CustomersAmazon's third annual Brand Protection Report highlights the company's investment in preventing the sale of counterfeit products on its platform and ensuring safe and authentic goods for customers.Learn More
- Intellectual Property: A Primer for BusinessesIssues surrounding intellectual property rights in the U.S. have a significant impact on the business community. Here’s what businesses need to know.Learn More
- How Can the U.S. Government Better Protect Companies from CyberattacksHere are some ways government leaders are protecting the United States from cyberattacks that could steal intellectual property and personal data.Learn More
Become a member
U.S. Chamber members range from the small businesses and local chambers of commerce that line the Main Streets of America to leading industry associations and large corporations.
Learn more about how your business can become a member.
Our Work
The U.S. Chamber’s Global Innovation Policy Center champions innovation and creativity through intellectual property standards so businesses can save lives, solve problems, create jobs, advance growth, and enhance society. Our work to protect strong intellectual property rights begins in Washington, D.C., and extends to countries across the globe.
Related Litigation
Small business advice from CO—
Events
- Corporate Social ResponsibilityThe Role of Public-Private Partnerships to Combat Human TraffickingMonday, July 1708:30 AM EDT - 01:45 PM EDTLearn More
- WorkforceT3 Innovation Network’s Mid-Year MeetingWednesday, July 1908:00 AM EDT - 06:00 PM EDTLearn More
- EconomySwing and a Miss: SEC’s Swing Pricing Proposal Is a Strikeout for InvestorsThursday, July 2009:00 AM EDT - 10:30 AM EDTLearn More
Latest Content
This Hill letter was sent to the Members of the Senate Committee on Appropriations, on the FY24 Commerce, Justice, Science, and Related Agencies Appropriations Legislation.
This Hill letter was sent to the Members of the Senate Committee on Appropriations, on the Fiscal Year 2024 Financial Services and General Government Appropriations bill.
This Hill letter was sent to the Members of the House Committee on Appropriations, on the Fiscal Year 2024 Financial Services and General Government Appropriations bill.
This Hill letter was sent to the Members of the House Committee on Appropriations, on the Fiscal Year 2024 Homeland Security Appropriations bill.
This Hill letter was sent to the Members of the Senate Committee on the Judiciary, opposing S. 1094, the "Journalism Competition and Preservation Act (JCPA) of 2023."
This Statement for the Record was sent to the Senate HELP Committee for the hearing, "The Need to Make Insulin Affordable for All Americans."
This Hill letter was sent to the Members of the Senate Committee on Health, Education, Labor and Pensions, on S. 1067, the "Ensuring Timely Access to Generics Act of 2023,” S. 1114, the “Expanding Access to Low-Cost Generics Act of 2023,” S. 1214, the “RARE Act,” and S. 1339, the “Pharmacy Benefit Manager Reform Act.”
